Contact

Media Releases

2021

24/11/2021

FDA advises regulatory pathway for PromarkerD in US
23/11/2021

PromarkerD distribution network expands to Britain
05/11/2021

PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline
03/11/2021

Proteomics International awarded $100,000 manufacturing funding
12/08/2021

Proteomics International contracts Biotem to manufacture PromarkerD test kits
11/08/2021

Diabetes treatment lowers PromarkerD risk score: Results presented at Australasian Diabetes Congress
22/07/2021

Proteomics engages Abcam to manufacture PromarkerD reagents
16/07/2021

Diabetes treatment lowers PromarkerD risk score: Results to be presented at Australasian Diabetes Conference
28/06/2021

World-first predictive test for Diabetic Kidney Disease could save $384 billion over 10 years
10/06/2021

CCO and CFO appointed to bolster executive team
< Older posts
Newer posts >

News Archive